Clinical studies and real-world evidence have an essential function in the enhancement of women’s health. They provide substantial scientific advancements in the prevention, detection, and management of diseases and conditions, largely impacting women’s health. The conditions under scrutiny range from women’s reproductive health, breast and cervical cancers or osteoporosis to a wide spectrum of health matters that remarkably impact the general wellness and life quality of women.

Despite the progress made, there are several common bottlenecks that researchers often encounter when it comes to studies involving women. These issues can hinder the progress of studies and impact the generalizability and applicability of findings.

1. Underrepresentation in Clinical Trials: Historically, women have been underrepresented in clinical trials, leading to a lack of gender-specific data and limited understanding of how certain diseases and treatments affect.
2. Recruitment and Retention Challenges: Recruiting an adequate number of women participants for clinical and RWE studies can be challenging. Factors such as geographical barriers, lack of awareness, socioeconomic disparities, and personal commitments may affect women’s willingness or ability to participate. Retention throughout the study duration can also be an obstacle, impacting the overall study power and validity of results.
3. Limited Representation of Diverse Populations: Ensuring diversity within study populations is crucial to account for variations related to ethnicity, age, socioeconomic status, and comorbidities. However, racial and ethnic minorities, older women, and those with comorbid conditions are often underrepresented in research.
4. Ethical Considerations: Women’s unique reproductive health, hormonal fluctuations, and pregnancy potential raise ethical concerns in clinical research involving women. These considerations may result in exclusion criteria or additional safety precautions, which can further limit the participation of women in studies targeting certain health conditions or treatments.
5. Data Collection and Analysis: Collecting and analyzing comprehensive sex-specific data require appropriate study design, data collection methods, and statistical analyses. This necessitates the development of validated sex-specific outcome measures, standardizing data collection across studies, and distinguishing between biological sex and gender-related factors.

Innovations in technology, such as virtualization and decentralization of the studies, have brought exciting opportunities to advance women’s health studies. These solutions enable the involvement of a diverse range of participants, regardless of geographical location, ensuring increased inclusivity and representation. Remote management offers greater flexibility and convenience for participants, making it easier for them to contribute valuable data.

Evidilya’s digital tools (VISA, Lucah App, concierge service) have already shown tremendous promise by accelerating the entire research process without compromising the quality of the results. Our technology enables researchers to capture real-time data, monitor health outcomes remotely, and gain insights that were previously inaccessible.

Reach out to us for more information! We will be delighted to address any questions or doubts you may have. Let’s embark on this exciting journey of advancing women’s health together!